Market Research Logo

Global Endocrinology Drugs Market 2018-2022

Global Endocrinology Drugs Market 2018-2022

About Endocrinology Drugs

Endocrinology is a branch of biology and medicine concerned with the study of the endocrine system. Endocrine disorders include diabetes, thyroid hormone disorders, and sexual dysfunction.
Technavio’s analysts forecast the Global Endocrinology Drugs Market to grow at a CAGR of 6.48% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the endocrinology drugs market. To calculate the market size, the report considers the revenue generated from the sales of endocrinology drugs.
Technavio's report, endocrinology drugs market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Key vendors

Abbvie
Merck
Novo Nordisk
Pfizer

Market driver

Increase in patient awareness
For a full, detailed list, view our report

Market challenge

Shortage of endocrinologists
For a full, detailed list, view our report

Market trend

Use of biosimilars for endocrine disorders
For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


PRESS RELEASE

Technavio Announces the Publication of its Research Report – Global Endocrinology Drugs Market 2018-2022

Technavio recognizes the following companies as the key players in the endocrinology drugs market: Abbvie, Merck, Novo Nordisk, and Pfizer.

Commenting on the report, an analyst from Technavio’s team said: “the use of biosimilars for endocrine disorders to be one of the major trends in the market” A biosimilar is a biologic product that is approved based on demonstrating that it is similar to an approved biologic product, known as a reference product.

According to the report, one driver influencing this market is the increasing incidence of endocrine disorders. The increase in incidence of endocrine disorders may be due to the rising aging population globally. A trend that is generally seen in the incidence of endocrinology disorders such as diabetes is that the incidence is generally higher in low-and middle-income countries.

Further, the report states that one challenge affecting this market is the reimbursement challenges. Most endocrine disorders pose a significant economic burden on patients as well as on healthcare systems. Physicians and patients have concerns regarding inadequate reimbursement for most endocrine disorders, including diabetes.

Companies Mentioned

Abbvie
Merck
Novo Nordisk
Pfizer

  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global pharmaceutical drugs market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Pipeline analysis
    • Table Pipeline molecules for hGH
    • Table Pipeline molecules for other endocrine disorders
    • Table Pipeline molecules for diabetes
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Annual global sales of leading endocrine disorder products 2015-2017
      • Table Global endocrinology drugs market - Market size and forecast 2017-2022 ($ bn)
      • Table Global endocrinology drugs market - Year over year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2017
  • Market segmentation by therapy area
    • Segmentation by therapy area
      • Table Global endocrinology drugs market by therapy area - Market share 2017-2022 (%)
    • Comparison by therapy area
      • Table Comparison by therapy area
    • Diabetes drugs - Market size and forecast 2017- 2022
      • Table Diabetes drugs - Market size and forecast 2017-2022 ($ bn)
      • Table Diabetes drugs - Year over year growth 2018-2022 (%)
    • Thyroid hormone disorder drugs - Market size and forecast 2017-2022
      • Table Thyroid hormone disorder drugs - Market size and forecast 2017-2022 ($ bn)
      • Table Thyroid hormone disorder drugs - Year over year growth 2018-2022 (%)
    • hGH - Market size and forecast 2017-2022
      • Table hGH - Market size and forecast 2017-2022 ($ bn)
      • Table hGH - Year over year growth 2018-2022 (%)
    • Testosterone replacement therapy - Market size and forecast 2017-2022
      • Table Testosterone replacement therapy - Market size and forecast 2017-2022 ($ bn)
      • Table Testosterone replacement therapy - Year over year growth 2018-2022 (%)
    • Others - Market size and forecast 2017-2022
      • Table Others - Market size and forecast 2017-2022 ($ bn)
      • Table Others - Year over year growth 2018-2022 (%)
    • Market opportunity by therapy area
      • Table Market opportunity by therapy area
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global endocrinology drugs market by region - Market share 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Americas - Market size and forecast 2017-2022
      • Table Endocrinology drugs market in Americas - Market size and forecast 2017-2022 ($ bn)
      • Table Endocrinology drugs market in Americas - Year over year growth 2018-2022 (%)
      • Table Top 3 countries in Americas
    • EMEA - Market size and forecast 2017-2022
      • Table Endocrinology drugs market in EMEA - Market size and forecast 2017-2022 ($ bn)
      • Table Endocrinology drugs market in EMEA - Year over year growth 2018-2022 (%)
      • Table Top 3 countries in EMEA
    • APAC - Market size and forecast 2017-2022
      • Table Endocrinology drugs market in APAC - Market size and forecast 2017-2022 ($ bn)
      • Table Endocrinology drugs market in APAC - Year over year growth 2018-2022 (%)
      • Table Top 3 countries in APAC
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Association between obesity and endocrine disorders
    • Use of biosimilars for endocrine disorders
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Abbvie
      • Table Abbvie overview
      • Table Abbvie - Business segments
      • Table Abbvie - Organizational developments
      • Table Abbvie - Geographic focus
      • Table Abbvie - Segment focus
      • Table Abbvie - Key offerings
    • Merck
      • Table Merck overview
      • Table Merck - Business segments
      • Table Merck - Organizational developments
      • Table Merck - Geographic focus
      • Table Merck - Segment focus
      • Table Merck - Key offerings
    • Novo Nordisk
      • Table Novo Nordisk overview
      • Table Novo Nordisk - Business segments
      • Table Novo Nordisk - Organizational developments
      • Table Novo Nordisk - Geographic focus
      • Table Novo Nordisk - Segment focus
      • Table Novo Nordisk - Key offerings
    • Pfizer
      • Table Pfizer overview
      • Table Pfizer - Business segments
      • Table Pfizer - Organizational developments
      • Table Pfizer - Geographic focus
      • Table Pfizer - Segment focus
      • Table Pfizer - Key offerings
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report